A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
Two European partners will soon be vying for dominance in a new battleground: vaccines to protect travelers against a painful ...
Bavarian Nordic has an annual production capacity of 30 million doses. According to the drugmaker's Vice President Sass Sørensen, the vaccine is “in stock in numerous countries” and can be ...
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in ...
People wait in line for a monkeypox vaccine at one of the few Chicago locations distributing the shot on Monday, July 25, 2022. With vaccine in extremely short supply, this clinic can currently only ...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic ...
Cases of mpox, formerly known as monkeypox, are on the rise at the start of 2024, according to Centers for Disease Control ...
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of ...
Notes/observations - Sweden Central Bank (Riksbank) starts easing for first time since 2016, amid inflation approaching target and weaker economic activity; Sees two more cuts in ...
With mpox infections once again on the rise among gay men, one out member of Congress is calling for big changes to the Department of Health and Human Services. Rep. Ritchie Torres, who represents ...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a ...